{
    "organizations": [],
    "uuid": "b193bdf27ce8cd3a45a455d9fdf07b17b430a97c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-novo-nordisk-says-semaglutide-inje/brief-novo-nordisk-says-semaglutide-injection-is-now-available-across-canada-idUSFWN1QN0HO",
    "ord_in_thread": 0,
    "title": "BRIEF-Novo Nordisk Says Semaglutide Injection Is Now Available Across Canada",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Novo Nordisk A/S:\n* NOVO NORDISK - OZEMPIC(Â®) (SEMAGLUTIDE INJECTION) IS NOW AVAILABLE ACROSS CANADA Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-03-05T21:11:00.000+02:00",
    "crawled": "2018-03-06T22:18:58.061+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "novo",
        "nordisk",
        "novo",
        "nordisk",
        "ozempic",
        "semaglutide",
        "injection",
        "available",
        "across",
        "canada",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}